Abstract
Background
Bone grafts are frequently used to supplement bone stock and to establish structural stability. However, graft-associated infection represents a challenging complication leading to increased patient morbidity and healthcare costs.
Questions/purposes
We therefore designed this study to (1) determine if increasing initial S. aureus inoculation of bone allograft results in a proportionate increase in colonization; (2) assess if antibiotics decrease colonization and if antibiotic tethering to allograft alters its ability to prevent bacterial colonization; and (3) determine if covalent modification alters the allograft topography or its biological properties.
Methods
Allograft bone and vancomycin-modified bone (VAN-bone) was challenged with different doses of S. aureus for times out to 24 hours in the presence or absence of solution vancomycin. Bacterial colonization was assessed by fluorescence, scanning electron microscopy (SEM), and by direct colony counting. Cell density and distribution of osteoblast-like cells on control and modified allograft were then compared.
Results
Bacterial attachment was apparent within 6 hours with colonization and biofilm formation increasing with time and dose. Solution vancomycin failed to prevent bacterial attachment whereas VAN-bone successfully resisted colonization. The allograft modification did not affect the attachment and distribution of osteoblast-like cells.
Conclusions
Allograft bone was readily colonized by S. aureus and covered by a biofilm with especially florid growth in natural topographic niches. Using a novel covalent modification, allograft bone was able to resist colonization by organisms while retaining the ability to allow adhesion of osteoblastic cells.
Clinical Relevance
Generation of allograft bone that can resist infection in vivo would be important in addressing one of the most challenging problems associated with the use of allograft, namely infection.
Similar content being viewed by others
References
Ahlmann E, Patzakis M, Roidis N, Shepherd L, Holtom P. Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes. J Bone Joint Surg Am. 2002;84:716–720.
Antoci V, Adams CS, Hickok NJ, Shapiro IM, Parvizi J. Antibiotics for local delivery systems cause skeletal cell toxicity in vitro. Clin Orthop Relat Res. 2007;462:200–206.
Antoci V, Adams CS, Parvizi J, Ducheyne P, Shapiro IM, Hickok NJ. Covalently attached vancomycin provides a nanoscale antibacterial surface. Clin Orthop Relat Res. 2007;461:81–87.
Arbeit RD, Dunn RM. Expression of capsular polysaccharide during experimental focal infection with Staphylococcus aureus. J Infect Dis. 1987;156:947–952.
Aro HT, Aho AJ. Clinical use of bone allografts. Ann Med. 1993;25:403–412.
Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res. 1996;329:300–309.
Boyce T, Edwards J, Scarborough N. Allograft bone. The influence of processing on safety and performance. Orthop Clin North Am. 1999;30:571–581.
Buttaro M, Comba F, Piccaluga F. Vancomycin-supplemented cancellous bone allografts in hip revision surgery. Clin Orthop Relat Res. 2007;461:74–80.
Buttaro MA, Morandi A, Rivello HG, Piccaluga F. Histology of vancomycin-supplemented impacted bone allografts in revision total hip arthroplasty. J Bone Joint Surg Br. 2005;87:1684–1687.
Cleary J, Rogers P, Chapman S. Variability in polyene content and cellular toxicity among deoxycholate amphotericin B formulations. Pharmacotherapy. 2003;23:572–578.
Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350:1422–1429.
Day RE, Megson S, Wood D. Iontophoresis as a means of delivering antibiotics into allograft bone. J Bone Joint Surg Br. 2005;87:1568–1574.
Delloye C, Cornu O, Druez V, Barbier O. Bone allografts: what they can offer and what they cannot. J Bone Joint Surg Br. 2007;89:574–579.
Desai BM. Osteobiologics. Am J Orthop. 2007;36(Suppl):8–11.
Dick HM, Strauch RJ. Infection of massive bone allografts. Clin Orthop Relat Res. 1994;306:46–53.
Edupuganti OP, Antoci V, King SB, Jose B, Adams CS. Covalent bonding of vancomycin to Ti6Al4V alloy pins provides long-term inhibition of Staphylococcus aureus colonization. Bioorg Med Chem Lett. 2007;17:2692–2696.
Elek SD, Conen PE. The virulence of Staphylococcus pyogenes for man: a study of the problems of wound infection. Br J Exp Pathol. 1957;38:573–586.
Farfalli GL, Buttaro MA, Piccaluga F. Femoral fractures in revision hip surgeries with impacted bone allograft. Clin Orthop Relat Res. 2007;462:130–136.
Finkemeier CG. Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am. 2002;84:454–464.
Fux CA, Stoodley P, Hall-Stoodley L, Costerton JW. Bacterial biofilms: a diagnostic and therapeutic challenge. Expert Rev Anti Infect Ther. 2003;1:667–683.
Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2:95–108.
Hicok KC, Thomas T, Gori F, Rickard DJ, Spelsberg TC, Riggs BL. Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma. J Bone Miner Res. 1998;13:205–217.
James RC, MacLeod CJ. Induction of staphylococcal infections in mice with small inocula introduced on sutures. Br J Exp Pathol. 1961;42:266–277.
Jofe MH, Gebhardt MC, Tomford WW, Mankin HJ. Reconstruction for defects of the proximal part of the femur using allograft arthroplasty. J Bone Joint Surg Am. 1988;70:507–516.
Ketonis C, Parvizi J, Adams CS, Shapiro IM, Hickok NJ. Topographic features retained after antibiotic modification of Ti alloy surfaces: retention of topography with attachment of antibiotics. Clin Orthop Relat Res. 2009;467:1678–1687.
Lentino JR. Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis. 2003;36:1157–1161.
Lewandrowski KU, Schollmeier G, Ekkemkamp A, Uhthoff HK, Tomford WW. Incorporation of perforated and demineralized cortical bone allografts. Part I: radiographic and histologic evaluation. Biomed Mater Eng. 2001;11:197–207.
Lewandrowski KU, Tomford WW, Schomacker KT, Deutsch TF, Mankin HJ. Improved osteoinduction of cortical bone allografts: a study of the effects of laser perforation and partial demineralization. J Orthop Res. 1997;15:748–756.
Lord CF, Gebhardt MC, Tomford WW, Mankin HJ. Infection in bone allografts. Incidence, nature, and treatment. J Bone Joint Surg Am. 1988;70:369–376.
Ma T, Gutnick J, Salazar B, Larsen MD, Suenaga E, Zilber S, Huang Z, Huddleston J, Smith RL, Goodman S. Modulation of allograft incorporation by continuous infusion of growth factors over a prolonged duration in vivo. Bone. 2007;41:386–392.
Mankin HJ, Hornicek FJ, Raskin KA. Infection in massive bone allografts. Clin Orthop Relat Res. 2005;432:210–216.
Muscolo DL, Ayerza MA, Calabrese ME, Gruenberg M. The use of a bone allograft for reconstruction after resection of giant-cell tumor close to the knee. J Bone Joint Surg Am. 1993;75:1656–1662.
Percival SL, Kite P. Intravascular catheters and biofilm control. J Vasc Access. 2007;8:69–80.
Sanford BA, de Feijter AW, Wade MH, Thomas VL. A dual fluorescence technique for visualization of Staphylococcus epidermidis biofilm using scanning confocal laser microscopy. J Ind Microbiol. 1996;16:48–56.
Stamm WE. Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am J Med. 1991;91:65S–71S.
Thimm B, Unger R, Neumann H, Kirkpatrick C. Biocompatibility studies of endothelial cells on a novel calcium phosphate/SiO2-xerogel composite for bone tissue engineering. Biomed. Mater. 2008;3:15007.
Tomford WW, Thongphasuk J, Mankin HJ, Ferraro MJ. Frozen musculoskeletal allografts. A study of the clinical incidence and causes of infection associated with their use. J Bone Joint Surg Am. 1990;72:1137–1143.
Udipi K, Chen M, Cheng P, Jiang K, Judd D, Caceres A, Melder RJ, Wilcox JN. Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent. J Biomed Mater Res Part A. 2008;85:1064–1071.
Witsø E, Persen L, Benum P, Bergh K. Cortical allograft as a vehicle for antibiotic delivery. Acta Orthop. 2005;76:481–486.
Witsø E, Persen L, Løseth K, Bergh K. Adsorption and release of antibiotics from morselized cancellous bone. In vitro studies of 8 antibiotics. Acta Orthop. 1999 Jun 1;70(3):298–304.
Zimmerli W. Prosthetic-joint-associated infections. Best Pract Res Clin Rheumatol. 2006;20:1045–1063.
Acknowledgments
We thank the Musculoskeletal Transplant Foundation for providing samples for this work as well as for their generous support of these studies.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ketonis, C., Barr, S., Adams, C.S. et al. Bacterial Colonization of Bone Allografts: Establishment and Effects of Antibiotics. Clin Orthop Relat Res 468, 2113–2121 (2010). https://doi.org/10.1007/s11999-010-1322-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11999-010-1322-8